Holen Sie sich die Stockscreener-App
8.18
5.41%
0.42
Schlusskurs vom Vortag:
$7.76
Offen:
$7.7827
24-Stunden-Volumen:
43,222
Relative Volume:
0.18
Marktkapitalisierung:
$5.94M
Einnahmen:
$7.83M
Nettoeinkommen (Verlust:
$-8.28M
KGV:
-0.4847
EPS:
-16.8761
Netto-Cashflow:
$-6.85M
1W Leistung:
+12.75%
1M Leistung:
-1.68%
6M Leistung:
+63.27%
1J Leistung:
-93.06%
1-Tages-Spanne:
$7.2401
$8.6899
1-Wochen-Bereich:
$7.11
$8.6899
52-Wochen-Spanne:
$3.0765
$120.00
Moolec Science Sa Stock (MLEC) Company Profile
Firmenname
Moolec Science Sa
Sektor
Branche
Telefon
-
Adresse
-
Compare MLEC vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
8.18 | 5.94M | 7.83M | -8.28M | -6.85M | -16.88 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-27 | Eingeleitet | ROTH MKM | Buy |
Moolec Science Sa Aktie (MLEC) Neueste Nachrichten
Moolec Science SA (MLEC) Institutional Confidence - TradingKey
Moolec Science SA (MLECW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Moolec Science SA (MLECW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Moolec Science SA (MLECW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Moolec Science SA (MLECW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Moolec Science SA (MLECW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Moolec Science SA (MLECW) Institutional Confidence - TradingKey
Moolec Science SA (MLECW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moolec Science SA (MLECW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Moolec Science SA (MLEC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moolec Science SA (MLEC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Moolec Science SA (MLEC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Why Did This Nano-Cap Food Stock More Than Double In Value Today? - Stocktwits
Moolec Science Warrant (MLECW) Edges Higher at $0.02, Stuck at Key LevelSector Neutral Pair - newsline.com
Moolec Science (MLEC) Strengthens as Shares Approach Key Resistance LevelProtective Put - newsline.com
Number of shareholders of Moolec Science SA – NASDAQ:MLEC - TradingView
MLEC Q2 2025 Earnings: Narrower Loss Beats Estimates as SciTech Platform AdvancesEarnings Surprise Report - newsline.com
Number of shareholders of Moolec Science SA – NASDAQ:MLECW - TradingView
Moolec Science SA (MLEC) Q2 2025 Earnings: Narrowed Loss Surprises as Zero Revenue Path ContinuesForward EPS Estimate - newsline.com
MOOLEC SCIENCE SA (MLEC) Stock Chart - ChartMill
Moolec Science Regains Nasdaq Compliance but Faces Year-Long Monitoring - TipRanks
Moolec Science (MLEC) restores Nasdaq listing compliance but faces year of monitoring - Stock Titan
Moolec Science (MLEC) Gains 4.6% as Stock Approaches Key $7.91 Resistance LevelATR Stop - thelegaladvocate.com
Moolec Science SA (MLEC) Q2 2025 Earnings: Narrower-Than-Expected Loss Drives Positive Stock Movement - newsline.com
MLEC Q2 2025 Earnings: Narrower-than-Expected Loss as Company Advances Science PlatformProduct Revenue Analysis - thelegaladvocate.com
MLEC Q2 2025 Earnings: Narrowed Loss Beats Estimates as Operational Progress ContinuesEarnings Revision Downgrade - newsline.com
Moolec Science Warrant (MLECW) Holds at Penny Levels as Declines Exceed 5%Factor Momentum - newsline.com
Moolec Science (MLEC) Dips 2.81% as Shares Approach Key Support LevelInstitutional Sentiment - newsline.com
Moolec Science (MLEC) Slides 4.4% Amid Selling Pressure; Key Support at $7.06 in FocusSign of Weakness - newsline.com
MLEC Q2 2025 Earnings: Narrower Loss than Expected as Stock RisesPreliminary Results - The Legal Advocate
MLEC Q2 2025 Earnings: EPS Surprises to the Upside as Pre-Revenue Science Company Narrows LossEBITDA Margin Trends - Newser
Why Is Moolec Science S.A. (MLEC) Stock Down Today? - Meyka
MLEC Moolec EPS beats estimates but revenue plummets 285 yearoveryear shares declineSlow Growth Warning - The Legal Advocate
MSN Money - MSN
Moolec Science Shareholders Approve 2025 Accounts and Board Slate at May 13 AGM - TipRanks
Moolec Science shareholders approve financials, re-elect directors and auditor - Investing.com
[6-K] Moolec Science SA Current Report (Foreign Issuer) | MLEC SEC FilingForm 6-K - Stock Titan
Moolec Science completes 2026 safflower planting campaign By Investing.com - Investing.com South Africa
MLEC Director Core Daniel Joaquin Files Initial Ownership, May 14, 2026 - Meyka
Moolec Science completes 2026 safflower planting campaign - Investing.com
Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States - ACCESS Newswire
Safflower oil tops 60% GLA as Moolec finishes 2026 US planting push - Stock Titan
Moolec Science Swings to Profit on Subsidiary Deconsolidation in Latest Interim Results - TipRanks
Moolec Science Regains Nasdaq Compliance After Strengthening Equity Base - TipRanks
Moolec hits $11.3M equity to satisfy Nasdaq listing rules - Stock Titan
Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period - galvnews.com
Moolec Science (NASDAQ: MLEC) restores Nasdaq equity compliance - Stock Titan
TradingKey - TradingKey
MLEC stock extends its relentless rally, sees 35% boost today after change in shareholding - MSN
MLEC (Moolec) EPS beats estimates but revenue plummets 28.5% year-over-year, shares decline.IPO - newser.com
The working capital efficiency at Moolec (MLECW) | MLECW QX Earnings: Moolec Warrant Reports No Earnings DataDecline Phase - newser.com
Finanzdaten der Moolec Science Sa-Aktie (MLEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):